Utah Blood and Marrow Transplant Program, Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute, University of Utah, 2000 Circle of Hope, Clinic 2E, Salt Lake City, UT, 84112, USA.
Curr Hematol Malig Rep. 2022 Feb;17(1):25-30. doi: 10.1007/s11899-021-00642-4. Epub 2022 Jan 11.
For nearly 20 years, oncology specialty practices have been working to integrate telemedicine technologies into standard patient care models. However, hematology practices have been slower to adopt telemedicine due to traditional care models that rely on interdisciplinary regional care centers and their ability to provide comprehensive and centralized services. Patients have traditionally been able to access high-quality medical care, diagnostics, supportive care, and clinical trials from these regional care centers, but they are required to attend frequent in-person visits to access these services. Rural and underserved patients experience more barriers than their urban counterparts to access the same level of care.
The COVID-19 pandemic has elevated telemedicine into the forefront of care, highlighting both promise and limitations to incorporating telemedicine into specialty hematology care. Hematologists should consider the benefits of incorporating telemedicine technologies into standard-of-care practices to promote patient-centered care and provide equal access to all patient populations.
近 20 年来，肿瘤学专业实践一直在努力将远程医疗技术融入标准的患者护理模式中。然而，由于依赖于跨学科区域护理中心及其提供全面和集中服务的能力的传统护理模式，血液学实践采用远程医疗的速度较慢。传统上，患者可以从这些区域护理中心获得高质量的医疗护理、诊断、支持性护理和临床试验，但他们需要经常亲自就诊才能获得这些服务。农村和服务不足的患者获得与城市患者相同水平的护理的障碍比城市患者多。
COVID-19 大流行将远程医疗提升到了护理的前沿，突显了将远程医疗纳入专业血液学护理的前景和局限性。血液科医生应考虑将远程医疗技术纳入标准护理实践的好处，以促进以患者为中心的护理，并为所有患者群体提供平等的获取途径。
